JNJ.DE
Price:
$144.5
Market Cap:
$366.85B
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive banda...[Read more]
Industry
Drug Manufacturers - General
IPO Date
2007-12-28
Stock Exchange
XETRA
Ticker
JNJ.DE
According to Johnson & Johnson’s latest financial reports and current stock price. The company's current ROE is 20.94%. This represents a change of 300.27% compared to the average of 5.23% of the last 4 quarters.
The mean historical ROE of Johnson & Johnson over the last ten years is 24.77%. The current 20.94% ROE has changed -15.45% with respect to the historical average. Over the past ten years (40 quarters), JNJ.DE's ROE was at its highest in in the September 2023 quarter at 36.54%. The ROE was at its lowest in in the December 2017 quarter at -17.81%.
Average
24.77%
Median
23.44%
Minimum
2.16%
Maximum
51.11%
Discovering the peaks and valleys of Johnson & Johnson ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.08%
Maximum Annual ROE = 51.11%
Minimum Annual Increase = -90.80%
Minimum Annual ROE = 2.16%
Year | ROE | Change |
---|---|---|
2023 | 51.11% | 118.81% |
2022 | 23.36% | -17.18% |
2021 | 28.20% | 21.30% |
2020 | 23.25% | -8.53% |
2019 | 25.42% | -0.70% |
2018 | 25.60% | 1.08% |
2017 | 2.16% | -90.80% |
2016 | 23.49% | 8.46% |
2015 | 21.66% | -7.45% |
2014 | 23.40% | 25.29% |
The current ROE of Johnson & Johnson (JNJ.DE) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
34.23%
5-year avg
30.27%
10-year avg
24.77%
Johnson & Johnson’s ROE is less than The Coca-Cola Company (39.75%), less than The Procter & Gamble Company (28.53%), less than Microsoft Corporation (34.56%), greater than McDonald's Corporation (-172.91%), less than 3M Company (96.32%),
Company | ROE | Market cap |
---|---|---|
39.75% | $257.09B | |
28.53% | $370.64B | |
34.56% | $2.97T | |
-172.91% | $201.48B | |
96.32% | $67.84B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Johnson & Johnson using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Johnson & Johnson or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Johnson & Johnson's ROE?
How is the ROE calculated for Johnson & Johnson (JNJ.DE)?
What is the highest ROE for Johnson & Johnson (JNJ.DE)?
What is the 3-year average ROE for Johnson & Johnson (JNJ.DE)?
What is the 5-year average ROE for Johnson & Johnson (JNJ.DE)?
How does the current ROE for Johnson & Johnson (JNJ.DE) compare to its historical average?